Literature DB >> 22048625

Combination therapy: update on gastric cancer in East Asia.

M Teresa Villanueva.   

Abstract

Entities:  

Year:  2011        PMID： 22048625     DOI： 10.1038/nrclinonc.2011.171

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.

Authors:  Mitsuru Sasako; Shinichi Sakuramoto; Hitoshi Katai; Taira Kinoshita; Hiroshi Furukawa; Toshiharu Yamaguchi; Atsushi Nashimoto; Masashi Fujii; Toshifusa Nakajima; Yasuo Ohashi
Journal:  J Clin Oncol       Date:  2011-10-17       Impact factor: 44.544
  1 in total
  10 in total

1.  FBXL5 targets cortactin for ubiquitination-mediated destruction to regulate gastric cancer cell migration.

Authors:  Gang Cen; Hong-Hua Ding; Bin Liu; Wei-Dong Wu
Journal:  Tumour Biol       Date:  2014-05-28

2.  Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics.

Authors:  Jia-Qin Cai; Xiao-Wu Xu; Yi-Ping Mou; Ke Chen; Yu Pan; Di Wu
Journal:  Tumour Biol       Date:  2015-08-26

3.  Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy.

Authors:  Mozaffar Aznab; Omid Beiki; Kiumars Eslam Pia; Khosro Setayeshi; Mohamad Ali Hesami; Houshang Vrae
Journal:  J Gastrointest Cancer       Date:  2017-03

4.  Meta-analysis: glutathione S-transferase T1 null allele is associated with gastric cancer risk.

Authors:  Wei Sun; Li Yao; Benchun Jiang
Journal:  Tumour Biol       Date:  2013-08-23

5.  HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs.

Authors:  Xujun He; Zhengchuang Liu; Yingjie Xia; Ji Xu; Guocai Lv; Lu Wang; Tonghui Ma; Liping Jiang; Yiping Mou; Xiaoting Jiang; Jie Ma; Zhongkuo Zhao; Haibin Ni; Wenjuan Xu; Guoqing Ru; Dongsheng Huang; Houquan Tao
Journal:  Oncotarget       Date:  2017-01-03

Review 6.  The prognostic value of HOTAIR for predicting long-term prognosis of patients with gastrointestinal cancers.

Authors:  Yi Zhang; Li-Juan Wang; Wei-Feng Li; Xu Zhang; Xian-Jin Yang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 7.  The association between body mass index and the risk of different gastrointestinal cancers: A protocol for an overview of systematic reviews.

Authors:  Xueni Ma; Ya Gao; Jipin Li; Dekui Zhang; Jinhui Tian
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

8.  iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells.

Authors:  Yanan Xu; Xian Li; Xiulan Su
Journal:  Oncol Rep       Date:  2019-11-11       Impact factor: 3.906

9.  YEATS Domain Containing 4 Promotes Gastric Cancer Cell Proliferation and Mediates Tumor Progression via Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Sheqing Ji; Youxiang Zhang; Binhai Yang
Journal:  Oncol Res       Date:  2017-03-02       Impact factor: 5.574

10.  Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer.

Authors:  Zhi-Yuan Xu; Qi-Ming Yu; Yi-An Du; Li-Tao Yang; Rui-Zeng Dong; Ling Huang; Peng-Fei Yu; Xiang-Dong Cheng
Journal:  Int J Biol Sci       Date:  2013-06-28       Impact factor: 6.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.